Search

everythinglearnresearchcommunity

for

Search:↓

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Mesotherapy might be a useful addition to dental surgery to reduce drug use and side effects, but more research is needed.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Nanocarriers can improve antioxidant delivery to the skin but face safety and production challenges.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Hair transplantation is the best treatment for hair loss, with new technologies improving results, and stem cell and gene therapies may treat severe baldness in the future.

Mutant mice help researchers understand hair growth and related genetic factors.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Hair restoration surgery can have complications; success depends on patient education, careful planning, and proper execution.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

The project created a standardized system for classifying skin lesions in lab rats and mice.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Activating TRPV3 stops human hair growth.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Certain essential oils can activate a human skin receptor, potentially helping with skin disorders.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

An adult with Kawasaki disease experienced temporary heart failure but recovered without lasting heart damage.

Altering maternal cortisol during pregnancy can improve wool growth in Merino sheep.

Dimethyl-fumarate may cause temporary hair loss.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

Malnutrition can cause unusual eyelash growth and hair loss.

Plasmalogens activate a channel in cells that may stimulate hair growth.